Biotechnology company Tryp Therapeutics has signed a letter of intent with Boston-based Massachusetts General Hospital to fund a clinical trial investigating psilocybin-assisted psychotherapy in patients suffering from irritable bowel syndrome.
Mass General Hospital partners for IBS clinical trial
